| Interferon pathway in SLE: one key to unlocking the myst... |
19 |
| Type I interferons in host defence and inflammatory dise... |
15 |
| Characterisation of anifrolumab, a fully human anti-inte... |
14 |
| Mouse models of lupus: what they tell us and what they d... |
13 |
| 10 most important contemporary challenges in the managem... |
13 |
| First use of cenerimod, a selective S1P(1) receptor modu... |
12 |
| TNF-alpha and plasma albumin as biomarkers of disease ac... |
11 |
| Platelet-bound C4d, low C3 and lupus anticoagulant assoc... |
11 |
| Engaging African ancestry participants in SLE clinical t... |
10 |
| Obstetric antiphospholipid syndrome |
9 |
